Aurora B kinase is the downstream target of ATR
Aurora B kinase is the downstream target of ATR
批准号:
6999573
负责人:
BILL H CHANG
金额:
$5.35万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2006-07-31
关键词:
DNA replicationDNA replication originHeLa cellsSDS polyacrylamide gel electrophoresisataxia telangiectasiachromosome disorderschromosome movementenzyme activityhistonesimmunocytochemistryneoplastic processphosphatidylinositolsphosphorylationpostdoctoral investigatorprotein structure functionserine threonine protein kinase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Disruptions in accurate DNA replication and segregation during the cell cycle results in genomic instability and missegregation of chromosomes. Genomic instability has long been recognized as an important step in converting normal cells into neoplastic cells. Recently, an abnormal chromosomal phenotype has been described whereby there is a delay in the replication timing (DRT) of an entire chromosome. Chromosomes with DRT have been shown to be unstable and contribute to genomic instability. DRT chromosomes show a delay in the mitosis-specific phosphorylation of histone H-3 on serine 10 and a delay in mitotic chromosome condensation (DMC). H-3 phosphorylation has been shown to be an important step in chromosome condensation and segregation. Aurora B kinase is thought to be responsible for the phosphorylation of H-3. Recent results from the Thayer lab have shown that DRT chromosomes activate the replication checkpoint pathway via ATR. Therefore, I hypothesize that inhibition of Aurora B, either by inhibition of kinase activity or inhibition of recruitment to the chromosome, plays a direct role in the DMC phenotype. The objective is to characterize the link between DRT/DMC, the replication checkpoint, and Aurora B kinase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting PTPN11 dependent Hematologic Malignancies
-
批准号:10520047
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2019
-
负责人:BILL H CHANG
-
依托单位:
Targeting PTPN11 dependent Hematologic Malignancies
-
批准号:10057374
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2019
-
负责人:BILL H CHANG
-
依托单位:
Targeting PTPN11 dependent Hematologic Malignancies
-
批准号:10305637
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2019
-
负责人:BILL H CHANG
-
依托单位:
海外基金